JPS58146504A - α―インターフェロン製剤およびその製造方法 - Google Patents

α―インターフェロン製剤およびその製造方法

Info

Publication number
JPS58146504A
JPS58146504A JP57224785A JP22478582A JPS58146504A JP S58146504 A JPS58146504 A JP S58146504A JP 57224785 A JP57224785 A JP 57224785A JP 22478582 A JP22478582 A JP 22478582A JP S58146504 A JPS58146504 A JP S58146504A
Authority
JP
Japan
Prior art keywords
interferon
item
composition according
term
glycine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP57224785A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0543689B2 (enExample
Inventor
ヘンリー・キング・ホン・クワン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Schering Plough Corp
Original Assignee
Schering Plough Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Corp filed Critical Schering Plough Corp
Publication of JPS58146504A publication Critical patent/JPS58146504A/ja
Publication of JPH0543689B2 publication Critical patent/JPH0543689B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP57224785A 1981-12-23 1982-12-21 α―インターフェロン製剤およびその製造方法 Granted JPS58146504A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33405281A 1981-12-23 1981-12-23
US334052 1981-12-23
ZA82/8580 1982-11-19

Publications (2)

Publication Number Publication Date
JPS58146504A true JPS58146504A (ja) 1983-09-01
JPH0543689B2 JPH0543689B2 (enExample) 1993-07-02

Family

ID=23305374

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57224785A Granted JPS58146504A (ja) 1981-12-23 1982-12-21 α―インターフェロン製剤およびその製造方法

Country Status (3)

Country Link
JP (1) JPS58146504A (enExample)
KR (1) KR880002037B1 (enExample)
ZA (2) ZA828580B (enExample)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60228422A (ja) * 1984-04-26 1985-11-13 Suntory Ltd 安定化された生理活性物質製剤
JPS60243028A (ja) * 1984-04-28 1985-12-03 Kyowa Hakko Kogyo Co Ltd インタ−フエロンの可溶化方法
JPS6293300A (ja) * 1985-10-15 1987-04-28 エフ．ホフマン　―　ラ　ロシュ　アーゲー インタ−フエロン組成物
JPS6391331A (ja) * 1986-10-03 1988-04-22 Senjiyu Seiyaku Kk 眼科用水性組成物
JPS63146829A (ja) * 1986-07-18 1988-06-18 Chugai Pharmaceut Co Ltd 安定な顆粒球コロニ−刺激因子含有製剤
US5026772A (en) * 1987-09-01 1991-06-25 Yamanouchi Pharmaceutical Co., Ltd. Lyophilized pharmaceutical composition of neocarzinostatin derivative
WO1996016658A1 (en) * 1994-11-29 1996-06-06 Kyowa Hakko Kogyo Co., Ltd. Indolocarbazole derivative preparation
JP2005522422A (ja) * 2002-02-01 2005-07-28 シモダ、バイオテック（プロプライエタリー）リミテッド 医薬組成物
JP2009513682A (ja) * 2005-11-02 2009-04-02 セントロ デ インジエニエリア ジエネテイカ イ バイオテクノロジア 相乗的効果を奏する割合でγ−及びα−インターフェロンを含有する安定化製剤

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55102519A (en) * 1979-01-31 1980-08-05 Green Cross Corp:The Stabilization of interferon

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55102519A (en) * 1979-01-31 1980-08-05 Green Cross Corp:The Stabilization of interferon

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60228422A (ja) * 1984-04-26 1985-11-13 Suntory Ltd 安定化された生理活性物質製剤
JPS60243028A (ja) * 1984-04-28 1985-12-03 Kyowa Hakko Kogyo Co Ltd インタ−フエロンの可溶化方法
JPS6293300A (ja) * 1985-10-15 1987-04-28 エフ．ホフマン　―　ラ　ロシュ　アーゲー インタ−フエロン組成物
JPS63146829A (ja) * 1986-07-18 1988-06-18 Chugai Pharmaceut Co Ltd 安定な顆粒球コロニ−刺激因子含有製剤
JPS6391331A (ja) * 1986-10-03 1988-04-22 Senjiyu Seiyaku Kk 眼科用水性組成物
US5026772A (en) * 1987-09-01 1991-06-25 Yamanouchi Pharmaceutical Co., Ltd. Lyophilized pharmaceutical composition of neocarzinostatin derivative
WO1996016658A1 (en) * 1994-11-29 1996-06-06 Kyowa Hakko Kogyo Co., Ltd. Indolocarbazole derivative preparation
JP2005522422A (ja) * 2002-02-01 2005-07-28 シモダ、バイオテック（プロプライエタリー）リミテッド 医薬組成物
JP2009513682A (ja) * 2005-11-02 2009-04-02 セントロ デ インジエニエリア ジエネテイカ イ バイオテクノロジア 相乗的効果を奏する割合でγ−及びα−インターフェロンを含有する安定化製剤

Also Published As

Publication number Publication date
KR840002657A (ko) 1984-07-16
JPH0543689B2 (enExample) 1993-07-02
KR880002037B1 (ko) 1988-10-13
ZA828580B (en) 1983-10-26
ZA829344B (en) 1983-10-26

Similar Documents

Publication Publication Date Title
FI70794B (fi) Foerfarande foer stabilisering av en lyofiliserad farmaceutiskinterferonblandning
HU202761B (en) Process for producing stabilized erythropoietin compositions
JP3927248B2 (ja) Ｈｇｆ凍結乾燥製剤
US9907829B2 (en) Stable MIA/CD-RAP formulation
AU715571B2 (en) Stable pharmaceutical composition of BDNF
JPWO2000072873A1 (ja) Ｈｇｆ凍結乾燥製剤
TWI243057B (en) Formulations for protection of peg-interferon alpha conjugates
IE890854L (en) Lyophilized pharmaceutical preparations
JPS58146504A (ja) α―インターフェロン製剤およびその製造方法
JPH03505334A (ja) 凍結乾燥されたペプチド製剤
KR20100017354A (ko) 냉동 저장을 위한, 재조합 단백질의 액상 용액의 안정화
JPWO2002007724A1 (ja) Ｎ−［ｏ−（ｐ−ピバロイルオキシベンゼンスルホニルアミノ）ベンゾイル］グリシン・モノナトリウム塩・４水和物の凍結乾燥製剤およびその製造方法
JPH01146826A (ja) 白金化合物の凍結乾燥製剤
JP4679730B2 (ja) 溶解性に優れたフィブリノゲン製剤
JPH0692315B2 (ja) 腸管外投与しうる、貯蔵安定な、免疫刺激性製剤及びこれを製造する方法
CN101756912B (zh) 一种蛇毒凝血酶冻干粉针剂及其制备方法
JPS60260523A (ja) インタ−フエロンの凍結乾燥医薬組成物
JP3088744B2 (ja) フィブロネクチン組成物
JPS62223129A (ja) インタ−ロイキン−２組成物
US20020146409A1 (en) Methods for stabilizing lyophilized blood proteins
JPS61137828A (ja) γ−インタ−フエロン製剤組成物
AU738891B2 (en) Stable transglutaminase preparations and process for producing them
JP2000509036A (ja) 安定化された抗ｂ型肝炎ワクチンタブレット
JPH0853365A (ja) 経口用トロンビン製剤
JPS62149623A (ja) 安定なｇｒｆ製剤